Tagomics Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tagomics Limited - overview
Established
2020
Location
Cambridge, -, UK
Primary Industry
Biotechnology
About
Established in 2020 and based in Cambridge, UK, Tagomics Limited provides molecular diagnostics, biomarker discovery, and disease understanding. The company was co-founded by Dr. Jack Kennefick (CEO) and Dr. Robert Neely.
In February 2024, the firm raised GBP 6. 7 million in venture funding led by investor Calculus Capital, with participation from investors Illumina Ventures, IQ Capital, Agilent Ventures, Mercia Asset Management, Meltwind, and OMX Ventures. The company provides a proprietary multiomic platform that unlocks fragmentomic, epigenetic, and genomic features as well as other biological sources of disease-associated biomarkers. The platform of the company, when combined with cutting-edge bioinformatics and machine learning techniques, offers biological insights and a revolutionary breakthrough in genomics-based illness profiling and diagnostics.
The company plans to use the February 2024 funding to support the growth and development of its operations.
Current Investors
Mercia Asset Management, Agilent Ventures, Calculus Capital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy
Website
www.tagomics.com
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Tagomics Limited - timeline of key events
Tagomics Limited - financials
| Fiscal Year Ended | Jul 31, 2021 | Jul 31, 2022 | Jul 31, 2023 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
Tagomics Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.